Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2000-3-30
pubmed:databankReference
pubmed:abstractText
The development of experimental models of active autoimmune diseases can be difficult due to tolerance of autoantigens, but knockout mice, which fail to acquire tolerance to the defective gene product, provide a useful tool for this purpose. Using knockout mice lacking desmoglein 3 (Dsg3), the target antigen of pemphigus vulgaris (PV), we have generated an active disease model for this autoantibody-mediated disease. Dsg3(-/-) mice, but not Dsg3(+/-) littermates, produced anti-Dsg3 IgG that binds native Dsg3, when immunized with recombinant mouse Dsg3. Splenocytes from the immunized Dsg3(-/-) mice were then adoptively transferred into Rag-2(-/-) immunodeficient mice expressing Dsg3. Anti-Dsg3 IgG was stably produced in the recipient mice for more than 6 months without further boosting. This IgG bound to Dsg3 in vivo and disrupted the cell-cell adhesion of keratinocytes. Consequently, the recipient mice developed erosions in their oral mucous membranes with typical histologic findings of PV. In addition, the recipient mice showed telogen hair loss, as found in Dsg3(-/-) mice. Collectively, the recipient mice developed the phenotype of PV due to the pathogenic anti-Dsg3 IgG. This model will be valuable for developing novel therapeutic strategies. Furthermore, our approach can be applied broadly for the development of various autoimmune disease models.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-10021453, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-10025740, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-10233237, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-1522242, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-1720352, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-2686027, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-6681540, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-7040962, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-7438101, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-7539469, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-8040292, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-8143788, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-8227357, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-8512037, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-8601740, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-8637861, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-8718483, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-8906813, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-9166409, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-9257868, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-9326396, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-950490, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-9701552, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-9710446, http://linkedlifedata.com/resource/pubmed/commentcorrection/10712434-9795772
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0021-9738
pubmed:author
pubmed:issnType
Print
pubmed:volume
105
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
625-31
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:10712434-Animals, pubmed-meshheading:10712434-Antibodies, pubmed-meshheading:10712434-Autoantigens, pubmed-meshheading:10712434-Autoimmune Diseases, pubmed-meshheading:10712434-Cadherins, pubmed-meshheading:10712434-DNA-Binding Proteins, pubmed-meshheading:10712434-Desmoglein 1, pubmed-meshheading:10712434-Desmoglein 3, pubmed-meshheading:10712434-Disease Models, Animal, pubmed-meshheading:10712434-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:10712434-Fluorescent Antibody Technique, pubmed-meshheading:10712434-Hair, pubmed-meshheading:10712434-Immunization, pubmed-meshheading:10712434-Lymphocytes, pubmed-meshheading:10712434-Mice, pubmed-meshheading:10712434-Mice, Knockout, pubmed-meshheading:10712434-Molecular Sequence Data, pubmed-meshheading:10712434-Pemphigus, pubmed-meshheading:10712434-Phenotype, pubmed-meshheading:10712434-Recombinant Proteins, pubmed-meshheading:10712434-Spleen
pubmed:year
2000
pubmed:articleTitle
Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus.
pubmed:affiliation
Department of Dermatology, and. Department of Immunology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. amagai@mc.med.keio.ac.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't